Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Vera Korenblik
Observed name:
V. Korenblik
Institutions:
Amsterdam UMC Location University of Amsterdam,
Amsterdam University Medical Centers,
University of Amsterdam
Observed institutions:
Amsterdam UMC Location University of Amsterdam,
Amsterdam University Medical Centers,
University of Amsterdam
ORCID:
0000-0001-5254-6345
Observed ORCID:
0000-0001-5254-6345
OpenAlex ID:
A5017563773
Are neuromodulation interventions associated with changes in the gut microbiota? A systematic review
2022
·
Vera Korenblik
, Marlies E. Brouwer
, et al.
·
Neuropharmacology
·
26
PDF
From gut to glee: Is butyrate a promising antidepressant? A systematic review and mechanistic insights
2025
·
Vera Korenblik
, Natalia K.M. Schilder
, et al.
·
Brain Behavior and Immunity
·
16
Feasibility and acceptability of 8-week oral tributyrin supplementation as add on to antidepressant medication in patients with depression: a study protocol paper for a pilot, randomised controlled trial
2025
·
Vera Korenblik
, Aniko Korosi
, et al.
·
BMJ Open
·
3
PDF
Relationship between fecal short-chain fatty acids (SCFAs) and microbial SCFA pathways with depressive symptoms in Dutch adults
2026
·
Vera Korenblik
, Thomaz F. S. Bastiaanssen
, et al.
·
Translational Psychiatry
PDF
158. From Gut to Brain: How Butyrate May Influence Depressive Symptoms
2026
·
Vera Korenblik
, Thomaz F.S. Bastiaanssen
, et al.
·
Biological Psychiatry
Exploring the associations between fecal short-chain fatty acids and depressive symptoms in a Dutch adult urban sample
2026
·
V. Korenblik
, I. de Haas
, et al.
·
Neuroscience Applied
Butyrate’s effects on depressive symptoms and affect in young adults with depression: study protocol for a pilot randomized controlled trial
2023
·
V. Korenblik
, A. Korosi
, et al.
·
Neuroscience Applied
Show more works
View as search
Works count:
7
Citation count:
45
H-index:
3
I10-index:
2
Year
Topic
Type